Related by context. All words. (Click for frequent words.) 72 chi ^ sup 67 S1P ^ sub 65 MADRS score 65 univariate analyzes 64 logistic regression model 63 odds ratios ORs 63 ^ sup + 63 logistic regression analysis 63 ^ sup -1 63 Supplementary Table 62 ^ ^ sup 62 multivariate analyzes 62 #OHD 62 p = .# [002] 62 χ 62 CORE OM 62 confidence intervals CIs 62 mm ^ sup 62 univariate analysis 62 cm ^ sup 62 multivariable analysis 62 baseline FEV 61 bivariate analysis 61 ‰ ¥ 61 ANCOVA 61 allele frequencies 61 IPAH 61 % CI #.#-#.# [006] 61 Univariate analysis 61 Pearson correlation coefficient 61 univariate 61 % CI #.#-#.# [007] 60 ^ F FDG 60 airway hyperresponsiveness 60 albumin excretion rate 60 AUC0 60 bivariate 60 homozygotes 60 covariate 60 m ^ sup 60 CI -#.# 60 PSQI 60 Fig. 3b 60 HOMA IR 60 multivariate logistic regression 60 subscale scores 60 intact parathyroid hormone 60 familial aggregation 60 % Confidence Interval 60 MMSE score 60 multivariable adjusted 59 5 HTTLPR 59 isoprostane 59 -#.# ± [002] 59 β = 59 PaO 2 59 chronicity 59 ^ sup 59 ALT elevation 59 ß = 59 CVD mortality 59 depressive symptomatology 59 HbA 1c levels 59 PCWP 59 logistic regression 59 σ 59 δ 59 nmol liter 58 logistic regression analyzes 58 variance ANOVA 58 intima media thickness 58 leukocyte counts 58 = -#.# 58 SUVmax 58 ε 58 multiple logistic regression 58 r2 = 58 lowest tertile 58 HRCT 58 covariance 58 macroalbuminuria 58 MetS 58 ω 58 = #.#-#.# 58 rs# [004] 58 eosinophil count 58 regression coefficient 58 lymph node metastasis 58 ANOVA 58 logistic regression models 58 CR nPR 58 μmol L 58 explanatory variables 58 TT genotype 58 ^ sup #m 58 Visual Analogue Scale VAS 58 DRD2 58 ^ sub 58 alanine aminotransferase ALT 58 alanine aminotransferase 58 SGPT 58 seropositivity 58 leukocyte count 58 % CI #.#-#.# [008] 58 FDG uptake 58 abdominal adiposity 58 immunoreactivity 58 ρ 58 MDRD 58 Å -1 57 correlation coefficients 57 rs# [001] 57 NNT = 57 SCr 57 multivariate adjustment 57 Fig. 2A 57 subscore 57 serum homocysteine 57 nmol l 57 CI #.#-#.# [001] 57 Capacity FVC 57 conditional logistic regression 57 preoperative PSA 57 z = 57 etiologic 57 airway responsiveness 57 NIH CPSI 57 ν 57 mucosal inflammation 57 alexithymia 57 CHD mortality 57 sociodemographic characteristics 57 â ‰ ¥ 57 posttreatment 57 heterozygotes 57 euthymic patients 57 multivariate Cox 57 histological subtype 57 WOMAC pain 57 spirometric 57 interleukin IL -6 57 glycated hemoglobin levels 57 generalized estimating 57 p = #.# [003] 57 Hb A1C 57 HT 2A 57 sociodemographic factors 57 genotypic 57 Multivariate analysis 57 Fig. 3B 57 anemia hemoglobin 56 HAQ DI 56 Rating Scale BPRS 56 plasma leptin 56 ASCUS 56 -#.# log# 56 ALT elevations 56 tertiles 56 mol L 56 Poisson regression 56 serum albumin 56 albumin excretion 56 % CI #.#-#.# [004] 56 log# copies mL 56 DLCO 56 -5 -6 56 uM 56 Pearson correlation coefficients 56 prevalences 56 p = .# [001] 56 cystatin 56 Depressive symptoms 56 pg ml 56 % CI #.#-#.# [005] 56 ± SEM 56 interobserver 56 affective psychosis 56 mRNA expression 56 affective psychoses 56 HBeAg 56 confidence interval #.#-#.# 56 nonfatal MI 56 proband 56 pg mL 56 baseline HbA1c 56 P = .# 56 EDSS score 56 aspartate aminotransferase 56 #p# [003] 56 F FLT 56 tumor histology 56 multivariable Cox 56 LV dysfunction 56 mmol l 56 tertile 56 ^ [002] 56 F FDG uptake 56 clinicopathological 56 psychiatric comorbidities 56 HRQOL 56 TOP2A 56 lactate dehydrogenase 56 hip BMD 56 histologic subtype 56 Fig. 2C 56 HbF 56 mL/min/#.# m 2 56 interrater reliability 56 matrix metalloproteinase MMP 56 diabetes mellitus hypertension 56 % CI #.#-#.# [003] 56 ERalpha 56 TIMP 1 56 AUCs 56 atherothrombotic disease 56 Supplementary Fig 56 GABRA2 56 posttransplant 56 HbA 1c 56 serum urate levels 56 chi squared 56 PSA nadir 56 antibody titer 56 IGFBP 56 mol 56 PUFA intake 56 liver histology 56 differential gene expression 56 metabolite concentrations 55 microg 55 polygenic 55 serum IGF 55 EQ 5D 55 carotid IMT 55 coinfection 55 neutrophil counts 55 multiple linear regression 55 HbA 1C 55 hypogonadotropic hypogonadism 55 μg ml 55 nondiabetic patients 55 AST ALT 55 platelet reactivity 55 interleukin IL 55 pulmonary arterial 55 = .# 55 bronchoalveolar lavage 55 regression coefficients 55 arterial oxygen saturation 55 Logistic regression analysis 55 Hcy 55 Descriptive statistics 55 glucuronide 55 z ^ 55 creatinine ratio 55 p = NS 55 Fig. 3a 55 inhibin B 55 thyrotropin 55 HBeAg seroconversion 55 allergic sensitization 55 adiponectin concentrations 55 kidney allograft 55 Figure 1A 55 fig. S2 55 Ann Intern Med 55 HER2 expression 55 gastric carcinoma 55 α 55 estimated GFR 55 apolipoprotein B 55 pulmonary capillary wedge 55 pulvinar 55 multivariable logistic regression 55 hours postdose 55 logistic regressions 55 covariates 55 lymphopenia 55 extensive metabolizers 55 serum estradiol 55 Kaplan Meier analysis 55 sd = 55 interquartile range 55 interferon γ 55 RBC folate 55 gene polymorphism 55 bioavailable testosterone 55 nmol L. 55 meta regression 55 CFQ R 55 Suicidal ideation 55 interquartile range IQR 55 HLA DRB1 * 55 λ 55 behavioral disinhibition 55 Kruskal Wallis test 55 #β estradiol 55 recurrent venous thromboembolism 55 neutropaenia 55 Multivariate analyzes 55 rs# [003] 55 fractional anisotropy 55 fasting insulin 55 LV hypertrophy 55 interobserver reliability 55 SNP rs# [002] 55 % CI #.#-#.# [001] 55 premorbid 55 sputum eosinophils 55 receiving ISENTRESS 55 HRQL 55 τ 55 thyrotropin levels 55 intraobserver 55 diabetes dyslipidemia 55 Bonferroni correction 55 ADAS cog 55 TIMP 55 ^ [001] 55 serum creatinine levels 55 autonomic dysfunction 55 BMI z 55 leukocytosis 55 fibrosis progression 55 differentially expressed genes 55 Supplemental Figure 55 SELENA SLEDAI 55 ertapenem 55 PTPN# 55 serum cotinine levels 55 HbA1C levels 55 HRQoL 54 CD4 ^ sup 54 MMSE scores 54 mEq L 54 serum TSH 54 HOXB# 54 YMRS 54 Â ± 54 FeNO 54 HLA DR4 54 Kaplan Meier curve 54 μg liter 54 diastolic hypertension 54 immunostaining 54 Fig. 1D 54 probands 54 ≥ 54 hormone receptor status 54 rs# [002] 54 aminotransferase levels 54 psychiatric morbidity 54 prognostic factors 54 Leydig cell 54 atherothrombotic 54 intraclass correlation coefficient 54 PREZISTA r arm 54 serum concentrations 54 leukopenia 54 ADCS ADL 54 TNFalpha 54 tHcy 54 Crohn Disease Activity 54 PON1 gene 54 bronchial responsiveness 54 Eq. 54 QIDS SR 54 parous women 54 microvessel density 54 transgene expression 54 NMIBC 54 ischemic lesions 54 gene polymorphisms 54 multivariable analyzes 54 symptom exacerbation 54 fasting plasma 54 cell adhesion molecule 54 mg BID dose 54 monotonically 54 symptomatology 54 hypoxemia 54 adjunctive placebo 54 pCR 54 confidence interval CI 54 FEV1 54 IPSS 54 hepatic fibrosis 54 CIN3 54 extrapyramidal symptoms 54 multivariate analysis 54 CI #.#-#.# [002] 54 antiphospholipid antibodies 54 plasma pharmacokinetics 54 virological response 54 Socioeconomic status 54 carotid intima media 54 nonobese 54 nitrotyrosine 54 MBq 54 kg m² 54 karyotypes 54 subclinical hypothyroidism 54 comorbidity 54 min -1 54 categorical variables 54 endometrial thickness 54 CD4 CD8 54 ADAS Cog 54 highest tertile 54 normoxic 54 diabetes mellitus DM 54 urodynamic parameters 54 DAS# CRP 54 statistically nonsignificant 54 NIHSS score 54 #.# df = 54 urine albumin 54 CC genotype 54 deoxy 54 plasma lipids 54 prothrombotic 54 comorbid anxiety 54 neurodevelopmental impairment 54 Eur Urol 54 monozygotic twins 54 Subgroup analysis 54 bivariate analyzes 54 dyslipidaemia 54 plasma cortisol 54 pmol L 54 hypovitaminosis D 54 isoenzyme 54 primary aldosteronism 54 titers 54 PSADT 54 femoral neck BMD 54 parasitaemia 54 lumbar spine BMD 54 serum BDNF 54 Subgroup analyzes 54 μg dL 54 inhibin 54 cervical intraepithelial neoplasia 54 homozygosity 54 F FDG PET 54 convergent validity 54 ziprasidone 54 gastric cardia 54 rheumatoid factor 54 treat NNT 54 confounder 54 Supplementary Figs 54 tPSA 54 Logistic regression 54 Apgar scores 54 elevated ALT 54 IQR 54 atopic asthma 54 lymphocyte count 54 laboratory abnormalities 54 mH 54 5q 54 Serum concentrations 54 hemoglobin Hb 54 QTcF 53 rCBF 53 fig. S1 53 nmol L 53 #q# deletion syndrome 53 nmol 53 C#BL/#J mice 53 Score TOS 53 biopsy Gleason 53 microvascular complications 53 SGRQ 53 LPS induced 53 neoplastic 53 timepoints 53 recurrent VTE 53 maternal serum 53 postvaccination 53 rhinorrhea 53 IL#B 53 median survivals 53 serum parathyroid hormone 53 thromboembolic 53 indel 53 subthreshold 53 amisulpride 53 serum prostate 53 ECOG PS 53 #.#/#.# mm Hg [003] 53 β2 53 sociodemographic variables 53 lymphocytosis 53 CR CRu 53 QRS duration 53 glomerular filtration rate 53 mU liter 53 cm -3 53 Fig. 1c 53 impaired glucose metabolism 53 biochemical recurrence 53 gastric adenocarcinoma 53 postop 53 cortisol secretion 53 dopamine receptor gene 53 serum sodium 53 γ 53 urinary excretion 53 noncardiac 53 glycosylated hemoglobin HbA1c 53 metabolic dysregulation 53 Neuroticism 53 nT 53 atheroma volume 53 pmol 53 #:#-# [029] 53 kcal d 53 Brief Psychiatric 53 mIU ml 53 symptomatic VTE 53 asthma exacerbation 53 cytokeratin 53 intestinal permeability 53 echocardiographic parameters 53 e = mc 53 Insulin sensitivity 53 ± SD 53 GFAP 53 serum ALT 53 troponin T 53 extracapsular extension 53 Fig. 1b 53 Hazard Ratio HR 53 p ≤ 53 df = 53 TNF α 53 PON1 53 androgen suppression 53 MLH1 53 Kaplan Meier curves 53 coronary stenosis 53 microalbuminuria 53 OPRM1 53 apnea hypopnea 53 lymphovascular invasion 53 Hp2 2 53 TEAEs 53 IL#B gene 53 Kaplan Meier survival 53 Multiple logistic regression 53 kcal mol 53 RAEB 53 apo B 53 Kaplan Meier 53 creatine phosphokinase 53 serum lipid levels 53 serum cortisol 53 serum cotinine 53 epistasis 53 Doppler sonography 53 CDAI score 53 oxygen desaturation 53 APOE genotype 53 VKORC1 53 T2DM 53 Eur J Endocrinol 53 baseline serum creatinine 53 virologic breakthrough 53 + + className 53 Lumbar spine 53 somatoform disorders 53 karyotype 53 SNP rs# [001] 53 thyroid carcinoma 53 arterial thickening 53 affective disorders 53 μg d 53 baseline CD4 53 Fig. 1E 53 postintervention 53 adenotonsillectomy 53 #OHD levels 53 neoplasias 53 Fig. 1A 53 COMT genotype 53 statistically significant correlation 53 CIN2 + 53 Nature vol 53 BMI waist circumference 53 Symptom severity 53 Arch Intern Med 53 pulmonary vascular 53 bronchopulmonary dysplasia 53 prostate cancer CaP 53 allele frequency 53 foveal thickness 53 LV ejection fraction 53 hypoperfusion 53 Genotypic 53 methylenetetrahydrofolate reductase 53 BMI ≥ 53 phosphorylated tau 53 subclinical atherosclerosis 53 antitrypsin 53 conventional DMARDs 53 diffusivity 53 pairwise comparisons 53 D dimer 53 G allele 53 virologic responses 53 baseline FEV1 53 left ventricular diastolic 53 Montgomery Åsberg Depression 53 Fig. 2b 53 progesterone receptor PR 53 clinically meaningful reductions 53 silent myocardial ischemia 53 schizotypal traits 53 plasma adiponectin 53 fasting triglycerides 53 hematologic toxicity 53 chloride secretion 53 β 53 prognostic factor 53 breast cancer subtypes 53 hepatic enzymes 53 exhaled NO 53 μg L 53 monocyte chemoattractant protein 52 interindividual 52 periprocedural MI 52 virus HBV 52 NNRTI resistance 52 Multivariate logistic regression 52 Fig. 4c 52 Solid Tumors RECIST 52 serum potassium 52 serum testosterone 52 mL sec 52 homozygote 52 aminotransferases 52 κ 52 promoter polymorphism 52 CYP #D# 52 Fig. 2B 52 salivary cortisol 52 CYP#D# genotype 52 oxycodone CR 52 nonparametric 52 x ULN 52 serum HBV DNA 52 pN 52 β blockers 52 Main Outcome Measures 52 folate concentrations 52 nonvertebral fractures 52 HT 1A 52 prospectively defined 52 corrected QT interval 52 Multiple linear regression 52 radioligand 52 θ 52 atopy 52 diastolic blood pressures 52 serum leptin 52 CP CPPS 52 Replikin Count 52 axial length 52 corneal curvature 52 serologically active patients 52 mcg BID 52 leucopenia 52 Score IPSS 52 urothelial carcinoma 52 serum ferritin 52 interobserver agreement 52 plasma lipid 52 coagulopathy 52 cognitive affective 52 ha -1 52 callous unemotional traits 52 DAS# [002] 52 metaplasia 52 PANSS 52 baseline LDH 52 Angiotensin converting enzyme 52 microsatellite instability 52 DQB1 * 52 haemolysis 52 clinicopathological features 52 Fig. 2c 52 histologic subtypes 52 atherogenic dyslipidemia 52 Genetic variation 52 IFN α 52 comorbid conditions 52 Flu Cy 52 SSc 52 eNO 52 QoL 52 NT proBNP concentrations 52 tirofiban 52 echogenicity 52 Î ¼ 52 tumor necrosis 52 alpha2 52 corneal thickness 52 hemoglobin concentration 52 nonsignificant 52 atrophic gastritis 52 sUA 52 HepG2 cells 52 P ≤ 52 nonfasting triglyceride levels 52 vitreous haze 52 NYHA functional class 52 functional polymorphism 52 APACHE II 52 #q# [001] 52 plasma glucose concentration 52 erection hardness 52 SNHL 52 serum bilirubin 52 HADS 52 HF hospitalization 52 interindividual variability 52 cranial irradiation 52 angiographically 52 advanced neoplasia 52 Stent thrombosis 52 triiodothyronine 52 Univariate 52 hsCRP levels 52 #.#,#.# [002] 52 BPRS 52 visceral adiposity 52 dehydroepiandrosterone sulfate 52 poor metabolizers 52 glycated hemoglobin HbA1c 52 Hgb 52 umol L 52 myocardial fibrosis 52 Alanine 52 melanocytic nevi 52 H. influenzae 52 eotaxin 52 internalizing disorders 52 unpaired t 52 #ß 52 dysphoric 52 International Prostate Symptom 52 thickness IMT 52 CIBIC plus 52 mammographic density 52 sensitivity specificity 52 Fig. 1C 52 ^ Tc 52 ovarian carcinoma 52 hemodynamic parameters 52 comorbid disorders 52 J Clin Oncol 52 aged ≥ 52 cystatin C 52 diastolic velocity 52 cm -2 52 nM 52 statistical significance p 52 fig. S4 52 yr -1 52 missense mutations 52 kD 52 hemodynamic variables 52 genetic polymorphism 52 Ejection Fraction 52 rho = 52 linkage disequilibrium 52 multiplicative 52 BRCA1 mutation carriers 52 8 OHdG 52 Endothelial function 52 covariance ANCOVA 52 UPDRS 52 aetiology 52 MDRD equation 52 heterozygote 52 serum PTH 52 carotid artery thickness 52 hyperglycaemia 52 STN stimulation 52 serum retinol 52 -# mV [001] 52 mean baseline A1C 52 airway hyper responsiveness 52 Multivariate analysis showed 52 hypophosphatemia 52 transferrin saturation 52 neurocognitive function 52 erythrocyte sedimentation rate 52 subscores 52 Fig. 1B 52 reflux esophagitis 52 eosinophilia 52 oncologic outcomes 52 Pain Intensity 52 detrusor 52 microvessel 52 CI = 52 central corneal thickness 52 lymphocytic 52 comorbid 52 HCV genotype 52 RNFL thickness 52 attain statistical significance 52 Scale cognitive subscale 52 aspartate aminotransferase AST 52 mosaicism 52 TOP2A gene 52 ml kg 52 -#.# log# copies mL 52 PRADAXA #mg 52 metabolic parameters 52 argc 52 radiographic findings 52 dichotomized 52 SN #/#/# [003] 52 cortical activation 52 N. gonorrhoeae 52 5 hydroxytryptamine 52 luminosities 52 ug kg 52 shorter telomere length 52 cTnT 52 transaminase elevations 52 bronchopulmonary dysplasia BPD 52 PCa 52 elevated creatinine 52 fluticasone salmeterol 52 NHANES #-# 52 ≈ 52 intraventricular hemorrhage 52 monozygotic 52 comorbid depression 52 bladder carcinoma 52 murine model 52 somatic symptoms 52 immunoreactive 52 hematological parameters 52 hypothalamic pituitary 52 mm Hg systolic 52 chest radiograph 52 ALB # 52 CD4 + CD# 52 neoplasm 52 MIC# [001] 52 suboptimal adherence 51 FACIT 51 fetal malformations 51 GSTP1 51 NTx 51 DSM IV Axis 51 rhinoconjunctivitis 51 myeloperoxidase 51 invasive ductal 51 glutamyl 51 Bulk density 51 plasma folate 51 CagA 51 2n = 51 Kaplan Meier estimates 51 psychopathological symptoms 51 pulmonary dysfunction 51 serum folate concentrations 51 morphometric vertebral fractures 51 atopic disorders 51 ROC curves 51 IL 1ß 51 LDL HDL 51 oxyhemoglobin 51 variant allele 51 p# activation 51 uL 51 hemagglutination 51 pressor response 51 serum markers 51 ug mL 51 Index CDAI 51 cerebral perfusion 51 S. aureus colonization 51 T2D 51 CHADS2 51 GH deficiency 51 immunohistochemical 51 dermatologic toxicities 51 postdischarge 51 μV 51 Endothelial dysfunction 51 carcinoembryonic antigen 51 SLNB 51 prostate carcinoma 51 Figs. 51 bronchial hyperresponsiveness 51 PsA 51 MMSE 51 colorectal adenoma 51 symptom severity 51 collagenous colitis 51 HBeAg negative patients 51 Cronbach alpha 51 intestinal microflora 51 euthymic 51 immunohistochemical staining 51 penetrance 51 Fig. 4a 51 g cm 51 nonexposed 51 bronchoalveolar lavage fluid 51 NOAEL 51 residual confounding 51 hemoglobin concentrations 51 kΩ 51 intratumoral 51 hypercalciuria 51 Fig. 3c 51 tumorigenicity 51 Hb A1c 51 distensibility 51 inflammatory biomarkers 51 NIHSS 51 hyperintensity 51 lopinavir r arm 51 TP# mutations 51 GH IGF 51 parasitemia 51 C#BL/#J 51 serum urate 51 Y BOCS 51 TNF alpha IL 51 carotid plaques 51 histopathologic findings 51 suppl. 51 √ Hz 51 serum HCV RNA 51 plasminogen activator inhibitor 51 schizophreniform disorder 51 IFN γ 51 μmol 51 Leukemias 51 cytokine interleukin 51 differentially regulated 51 extramedullary 51 HGPIN 51 Recurrence Score 51 Tg mice 51 anti Mullerian hormone 51 sonographic findings 51 definite stent thrombosis 51 IIEF 51 HbA1c levels 51 intracellular Ca 2 51 ventricular repolarization 51 arterial thromboembolic events 51 CCyR 51 specific antigen PSA 51 dpa kr 51 childhood acute lymphoblastic 51 chromosomal aberrations 51 scintigraphic 51 hyperintensities 51 fractional shortening 51 ADPKD 51 colorectal adenocarcinoma 51 point Likert scale 51 ng dL 51 asthma exacerbations 51 J Urol 51 -#.# mg dL [002] 51 HIV uninfected 51 metabolic disturbances 51 nanomolar 51 μg kg 51 avoidant personality disorder 51 K + ATPase 51 elevated triglyceride levels 51 neurocognitive deficits 51 dose dependently 51 Scale Cognitive Subscale 51 pathophysiological 51 lactate dehydrogenase LDH 51 cTnI 51 adnexal mass 51 L methionine 51 TUNEL 51 xenobiotic 51 Genetic predisposition 51 Clusterin 51 retinol binding protein 51 dyspnea